Related Experiment Video
Updated: Jul 13, 2026
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
IKZF1 and KRAS Mutated B-cell Acute Lymphoblastic Leukemia with Pseudo-Chédiak-Higashi Granules
Taichi Murao1, Tohru Inaba2, Yusuke Yamane1
1Department of Hematology, Panasonic Health Insurance Organization Matsushita Memorial Hospital, Japan.
Insights
This study details a rare case of B-lymphoblastic leukemia (B-ALL) with Pseudo-Chediak-Higashi (PCH) granules. The patient’s leukemia was resistant to standard chemotherapy, indicating a need for further research.
Area of Science:
- Hematology
- Oncology
- Cell Biology
Background:
- B-lymphoblastic leukemia (B-ALL) is a significant hematologic malignancy.
- Pseudo-Chediak-Higashi (PCH) granules in lymphoblasts are an uncommon morphological finding.
- Understanding rare B-ALL variants is crucial for improving patient outcomes.
Purpose of the Study:
- To report a unique case of B-ALL with PCH granules.
- To investigate the morphological and genomic characteristics of this B-ALL variant.
- To highlight the diagnostic and therapeutic challenges associated with this condition.
Main Methods:
- Morphological analysis using transmission electron microscopy.
- Genomic analysis to identify specific mutations.
- Clinical case review of patient's response to induction chemotherapy.
Main Results:
- Heterogeneous lymphoblasts with irregular nuclei containing PCH granules (autophagosomes) were observed.
- Genomic analysis revealed IKZF1 and KRAS mutations.
- The patient's B-ALL was refractory to induction chemotherapy.
Conclusions:
- Morphological heterogeneity in B-ALL with PCH granules presents diagnostic difficulties.
- B-ALL with PCH granules refractory to induction therapy is rare and requires further study.
- Additional research is needed to elucidate the clinical and pathological features of this B-ALL subtype.
Abstract:
We present the case of a 78-year-old patient with B-cell acute lymphoblastic leukemia (B-ALL), characterized by the presence of pseudo-Chédiak-Higashi (PCH) granules in lymphoblasts. A morphological analysis using transmission electron microscopy revealed heterogeneous blasts with irregular and bilobed nuclei containing PCH granules, identified as autophagosomes. A genomic analysis revealed mutations in IKZF1 and KRAS. The patient's condition was refractory to induction chemotherapy. The morphological heterogeneity of B-ALL with PCH granules poses a diagnostic challenge. Few reports have so far described cases of B-ALL with PCH granules refractory to induction therapy, thus highlighting the need for further investigation to better understand its clinical and pathological features.
